Using new MRI scans to measure pancreatic tumor response
Part of Cancer clinical trials.
This study tests whether new MRI techniques can better show how pancreatic cancer responds to treatment. It compares standard CT scans with advanced MRI sequences for patients whose cancer has not spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have pancreatic cancer that has not spread beyond the pancreas (non-metastatic) based on a CT scan
- You are covered by French health insurance (social security)
- You have received all study information and signed a consent form
- You do not have any reason you cannot have an MRI (like metal implants or severe claustrophobia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new MRI technique that may help predict how well pancreatic cancer treatments will work. You would receive a special substance (called hyperpolarized pyruvate) during a standard MRI scan.
This study tests if a special MRI scan (MRE) can better diagnose pancreatic masses. It may help doctors find and treat pancreatic cancer more accurately.
This study tests a new, harmless “disposable” setup for MRI scans to measure how pancreatic cancer treatments affect the body. It may help doctors get more accurate MRI measurements, so treatment response can be assessed better.
This trial tests whether a special MRI scan can help doctors better plan treatment for people with pancreatic cancer that is borderline able to be removed by surgery. The study will check how the tumor responds to initial treatment before surgery.
This trial uses a special MRI scan called 3D MRE to see how well people with pancreatic cancer might do. It looks at the stiffness of the tumor and surrounding tissue to help predict outcomes.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
Hear when a new Pancreas Adenocarcinomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.